Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education.
This CME Activity is accredited with 4.25 AMA PRA Category 1 Creditsâ„¢.
Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Nurses, Technicians & Allied health should claim only the credit commensurate with the extent of their participation in the activity.
ACTIVITY DIRECTORS' WELCOME MESSAGE
Dear Esteemed Guests and Colleagues,
We are honored to welcome you to the Thyroid Cancer Update 2025 Webinar, a global gathering of minds united by a shared commitment to advancing thyroid cancer care. This platform brings together experts, clinicians, researchers, and learners from around the world to exchange insights, spark innovation, and elevate patient outcomes.
This year’s agenda is dynamic, spotlighting key developments and emerging strategies in thyroid cancer management:
- Conservative Management Approaches: Explore evolving techniques such as ‘active surveillance’, ‘radiofrequency ablation’, and the nuanced care of ‘small-volume recurrent neck disease’, all aimed at minimizing overtreatment while maintaining clinical efficacy.
- Guideline Review: The American Thyroid Association differentiated Thyroid Cancer guidelines, released in August 2025, for the diagnosis and management of differentiated thyroid cancer in adults.
- Guideline Preview: Gain early insight into the ‘proposed American Thyroid Association guidelines’ for thyroid nodule management, offering a glimpse into the future of standardized care.
- Advanced Treatment Strategies: Delve into ‘neoadjuvant therapies’ for advanced thyroid cancer and participate in a ‘multidisciplinary tumor board’ discussion tackling complex, real-world cases with collaborative expertise.
Thyroid Cancer Update 2025 is designed to foster meaningful collaboration between seasoned experts and emerging leaders. Through thought-provoking presentations and interactive discussions, we aim to challenge assumptions, share breakthroughs, and inspire new directions in care.
Your participation reflects a deep commitment to clinical excellence and a shared mission to improve the lives of those affected by thyroid cancer. Together, let us embrace the opportunities this webinar offers, to push the boundaries of knowledge and shape a brighter, more compassionate future for thyroid cancer care.
Warm Regards,
Dr. Samer El-Kaissi
Division Chair
Endocrinology
Medical Specialty Institute
Cleveland Clinic Abu Dhabi
Dr. Mahdi Shkoukani
Division Chair
Otolaryngology (ENT)
Integrated Surgical Institute
Cleveland Clinic Abu Dhab
EVENT OBJECTIVES
This education series aims to bring together medical practitioners and to keep them up to date on the latest evidence of diagnostic testing and management in Otolaryngology, Thyroid Disease, Head and Neck, Pathology and Reconstructive Surgery.
Agenda
Speakers / Moderators
Planning Committee
Target Audience
Round 2:
Endocrinologists, Endocrine Surgeons, Otolaryngologists, General surgeons, Medical Oncologists, Radiation Oncologists, Nuclear Medicine, Pathologists, Radiologists
ACCME Accreditation Statement
Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ACCME Credit Designation Statement
Cleveland Clinic Abu Dhabi designates this live activity for a maximum of XX.XX AMA PRA Category 1 Credits TM.
Physicians should obtain only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE AND CONFLICT OF INTEREST
The planning committee, faculty and others in control of content (either individually or as a group) have disclosed relevant financial relationships with ineligible companies. All relevant financial relationships have been reviewed and mitigated in accordance with ACCME standards.
Managed By
© MCO – Medetarian Conference Organizing | OTOLARYNGOLOGY ROUNDS 2025